Asia Pacific Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Range, Route of Administration, Indication, and Distribution Channel

Description

List of Tables

The APAC anti-infective agents market was valued at US$ 35,281.27 million in 2022 and is projected to reach US$ 43,478.22 million by 2028. It is expected to grow at a CAGR of 3.5% during the forecast period.

Continued development of new anti-infective agents is a major driving force behind the growth of the Asia Pacific anti-infective agents market. Developments in the medical devices industry have motivated existing players and new entrants to introduce their novel products in the market. Additionally, there have been lots of developments in techniques involved in medical examinations. The use of illuminating light sources with longer shelf life in gynecological procedures is encouraging market players to develop and introduce anti-infective agents.

TLRs, or toll-like receptors, are important components of innate immunity. They have the ability to detect a variety of microbes, including viruses, bacteria, fungi, and protozoa. Innate immunological reactions can directly influence adaptive immune reactions. Therefore, TLRs are considered therapeutic targets for autoimmune diseases, including autoimmune disorders, allergies, sepsis, and cancer. 2 COVID-19 vaccines were created using mRNA technology (Pfizer-BioNTech35 and Moderna36), demonstrating safety and high efficacy. Such developments are expected to present lucrative opportunities to the Asia Pacific anti-infective agent market in the years to come.

Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the Asia Pacific anti-infective agents market at a good CAGR during the forecast period.

Asia Pacific Anti-Infective AgentsMarket Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Anti-Infective Agents Market Segmentation

The Asia Pacific anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.

Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.

Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.

Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.

Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.

Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China is expected to hold the largest market share by the end of 2022.

Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the Asia Pacific anti-infective agents market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific anti-infective agents market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific anti-infective agents market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the anti-infective agents market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025820

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 APAC Anti-Infective Agents Market - By Type
- 1.3.2 APAC Anti-Infective Agents Market - By Range
- 1.3.3 APAC Anti-Infective Agents Market - By Route of Administration
- 1.3.4 APAC Anti-Infective Agents Market - By Indication
- 1.3.5 APAC Anti-Infective Agents Market - By Distribution Channel
- 1.3.6 APAC Anti-Infective Agents Market - By Country

2. APAC Anti-Infective Agents Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. APAC Anti-infective agents Market - Market Landscape

4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion

5. APAC Anti-Infectives Agents Market - Key Market Dynamics

5.1 Key Drivers
- 5.1.1 Rising Prevalence of Targeted Diseases
- 5.1.2 Research Activities and Clinical Trials Getting Government Support
5.2 Market Restraints
- 5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
- 5.3.1 New Anti-infective Agents Getting Developed
5.4 Future Trends
- 5.4.1 Surging Investments in R&D Activities in Pharmaceutical Sector
5.5 Impact Analysis

6. Anti-Infectives Agents Market - APAC Analysis

6.1 APAC Anti-Infectives Agents Market Revenue Forecast and Analysis

7. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 - Type

7.1 Overview
7.2 APAC Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.3 Anti-Viral
- 7.3.1 Overview
- 7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Bacterial
- 7.4.1 Overview
- 7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.5 Anti-Fungal
- 7.5.1 Overview
- 7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 - Range

8.1 Overview
8.2 APAC Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
- 8.3.1 Overview
- 8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
- 8.4.1 Overview
- 8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

9. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 - Route of Administration

9.1 Overview
9.2 APAC Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
- 9.3.1 Overview
- 9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
- 9.4.1 Overview
- 9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
- 9.5.1 Overview
- 9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 - Indication

10.1 Overview
10.2 APAC Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
- 10.3.1 Overview
- 10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
- 10.4.1 Overview
- 10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
- 10.5.1 Overview
- 10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
- 10.6.1 Overview
- 10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 - Distribution Channel

11.1 Overview
11.2 APAC Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
- 11.3.1 Overview
- 11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
- 11.4.1 Overview
- 11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
- 11.5.1 Overview
- 11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
- 11.6.1 Overview
- 11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
- 11.7.1 Overview
- 11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. APAC Anti-Infectives Agents Market Analysis and Forecasts To 2028 - Country Analysis

12.1 Overview
- 12.1.2 APAC: Anti-infective agents Market, by Country, 2022 & 2028 (%)
  - 12.1.2.1 China: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.1 China: Anti-infective agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.2 China: Anti-infective agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.2.1.3 China: Anti-infective agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.2.1.4 China: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.1.2.1.5 China: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
    - 12.1.2.1.6 China: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
  - 12.1.2.2 Japan: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.1 Japan: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.2 Japan: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
    - 12.1.2.2.3 Japan: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
    - 12.1.2.2.4 Japan: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.1.2.2.5 Japan: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
    - 12.1.2.2.6 Japan: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
  - 12.1.2.3 India: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.1 India: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.2 India: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
    - 12.1.2.3.3 India: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
    - 12.1.2.3.4 India: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.1.2.3.5 India: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
    - 12.1.2.3.6 India: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
  - 12.1.2.4 South Korea: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.4.1 South Korea: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.4.2 South Korea: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
    - 12.1.2.4.3 South Korea: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
    - 12.1.2.4.4 South Korea: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.1.2.4.5 South Korea: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
    - 12.1.2.4.6 South Korea: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
  - 12.1.2.5 Australia: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.5.1 Australia: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.5.2 Australia: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
    - 12.1.2.5.3 Australia: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
    - 12.1.2.5.4 Australia: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.1.2.5.5 Australia: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
    - 12.1.2.5.6 Australia: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)
  - 12.1.2.6 Rest of APAC: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.6.1 Rest of APAC: Anti-infective agents Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.6.2 Rest of APAC: Anti-infective agents Market, by Type, 2019-2028 (USD Million)
    - 12.1.2.6.3 Rest of APAC: Anti-infective agents Market, by Range, 2019-2028 (USD Million)
    - 12.1.2.6.4 Rest of APAC: Anti-infective agents Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.1.2.6.5 Rest of APAC: Anti-infective agents Market, by Indication, 2019-2028 (USD Million)
    - 12.1.2.6.6 Rest of APAC: Anti-infective agents Market, by Distribution Channel, 2019-2028 (USD Million)

13. Anti-infectives Agents Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
13.3 Organic Developments
- 13.3.1 Overview
- 13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
13.4 Inorganic Developments
- 13.4.1 Overview
- 13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022

14. Anti-Infectives Agents Market- Company Profiles

14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Allergan Plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Astellas Pharma Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Merck & Co., Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bayer AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Boehringer Ingelheim International GmbH
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Gilead Sciences, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 GlaxoSmithKline plc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Novartis AG
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms